1.
Kachhadia MP, Puri P, Patel K, Topiwala U, Shaikh JD, Borad N, et al. Sodium-Glucose Co-Transporter 2 Inhibitor Use and Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis and Type 2 Diabetes: A Retrospective Observational Cohort Study Using Real-World Data. J Clin Med Res [Internet]. 2026 Jan. 1 [cited 2026 Jun. 24];18(5):313-25. Available from: https://jocmr.elmerjournals.com/jocmr/article/view/6577